skip to main content

Lowenstein Sandler LLP | The contents of this website contain attorney advertising. | Results may vary depending on your particular facts and legal circumstances.

Search
Smart Search Icon
Header Search
view all search results
Search Close
Hamburger
profile Icon for Mobile

Annie Nazarian Davydov

Partner

New Jersey
T: +1 646.414.6922 F: +1 973.422.6827 anazarian@lowenstein.com
  • BIO
  • EXPERIENCE
  • HONORS & AWARDS
  • NEWS & INSIGHTS

See more section

Annie Nazarian Davydov concentrates in mergers and acquisitions, private equity, and securities and general corporate law matters.

Annie regularly advises public and private companies and private equity firms in a wide variety of U.S. and cross-border transactions and corporate matters, including acquisitions and dispositions, investments, joint ventures, spin-offs and carve-outs. She has represented clients across a diverse range of industry groups and sectors, including pharmaceuticals and medical devices, software services and consumer product goods.

Her clients look to her to resolve their complex problems in a direct manner and herald her as someone with excellent negotiation skills who can cut through to the heart of both the legal and business issues to get the deal done.

Annie was recognized as of the The Deal’s Top Rising Stars. She is actively involved in the firm’s training and mentorship programs.

  • Represented The Estée Lauder Companies Inc. in its acquisitions of Too Faced Cosmetics, By Kilian, GLAMGLOW, Parfums Frédéric Malle, and RODIN olio lusso.
  • Represented Avalon Globocare Corp., a commercial-stage company dedicated to developing and delivering precision diagnostic consumer products, in its entry into a Merger Agreement with YOOV Group Holding Limited (“YOOV”), a leading provider of business artificial intelligence (“AI”) automation solutions.
  • Represented Evergreen Theragnostics, Inc., a clinical-stage radiopharmaceutical company, in its sale to Lantheus Medical Imaging, Inc., a leading radiopharmaceutical-focused company.
  • Represented Cyabra Strategy Ltd., a data intelligence firm, in the signing of a $70,000,000 definitive merger agreement with Trailblazer Merger Corporation I (NASDAQ: TBMC), a special purpose acquisition company (SPAC).
  • Represented The Estée Lauder Companies Inc. (“ELC”) in a transaction to complete its acquisition of DECIEM Beauty Group Inc. (“DECIEM”), for approximately $860 million. Lowenstein Sandler had previously represented ELC in its initial investment in DECIEM in 2017 and again when ELC increased its stake in DECIEM to become a majority owner of the company in 2021.
  • Represented Kintara Therapeutics, Inc. (Nasdaq: KTRA) (“Kintara”), a biopharmaceutical company investigating REM-001 in an NIH-sponsored and funded open label study in cutaneous metastatic breast cancer, in its anticipated merger with TuHURA Biosciences, Inc. (“TuHURA”), a Phase 3 registration-stage immune-oncology company developing novel technologies to overcome resistance to cancer immunotherapy.
  • Represented Twill, Inc., a leader in digital-led care, in its sale to DarioHealth Corp. (NASDAQ: DRIO).
  • Represented Wedgewood Village Pharmacy LLC, a veterinary compounding pharmacy, in its acquisition of Front Range Laboratories, Inc.
SEE MORE

CLICK HERE FOR AWARD INFORMATION & METHODOLOGY

No aspect of these advertisements has been approved by the highest court of any state.

Education

  • New York University School of Law (J.D. 2010)

    University of California, Los Angeles (B.A. 2002), Political Science

Affiliations

  • Armenian Bar Association, New York- New Jersey Chapter

Admissions

  • New York
  • New Jersey

Related Areas

Additional Resources

Additional Resources

Subscribe